Home > Insider Trading > Filing (0000899243-16-029944)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1103021	Biodelivery Sciences International Inc	BDSI	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1066040	Jr E Francis Odonnell	C/O Biodelivery Sciences Intl, Inc., 4131 Parklake Avenue, Suite 225 Raleigh NC 27612		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2016-09-22	50,000	$2.45	1,335,490	No	4	S	Indirect	By HCG II, LLC
Common Stock	Disposition	2016-09-23	50,000	$2.68	1,285,490	No	4	S	Indirect	By HCG II, LLC

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	By HCG II, LLC
No	4	S	Indirect	By HCG II, LLC

Footnotes

On September 22, 2016, Hopkins Capital Group II, LLC ("HCGII") sold an aggregate of 50,000 shares of the Issuer's Common Stock at a weighted average price of $2.45 per share. The highest sale price for the Common Stock was $2.47 per share and the lowest sale price was $2.43 per share. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Represents all of the shares of the Issuer held by HCGII.
The shares are owned by HCGII. The Reporting Person is a discretionary beneficiary of an irrevocable spendthrift trust which directly owns a minority membership interest in HCGII. The Reporting Person disclaims ownership of all securities held by HCGII.
On September 23, 2016, HCGII sold an aggregate of 50,000 shares of the Issuer's Common Stock at a weighted average price of $2.68 per share. The highest sale price for the Common Stock was $2.81 per share and the lowest sale price was $2.58 per share. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.